US2019314620A1PendingUtilityA1

Apparatus and methods for dilating and modifying ostia of paranasal sinuses and other intranasal or paranasal structures

Assignee: ACCLARENT INCPriority: Apr 21, 2004Filed: May 29, 2019Published: Oct 17, 2019
Est. expiryApr 21, 2024(expired)· nominal 20-yr term from priority
A61B 2090/3925A61B 2018/00327A61B 2018/1415A61B 2018/0022A61B 2018/00595A61B 2018/00238A61B 18/1492A61B 2090/3966A61B 2090/376A61M 29/02A61F 2250/0067A61F 2/958A61F 2/86A61B 2017/22061A61B 2017/22055A61B 2017/22039A61B 2017/00323A61B 2017/003A61B 17/3478A61B 17/320725A61B 17/32002A61B 17/24A61B 2034/2051A61F 2/95A61M 25/0147A61M 2210/0681A61M 2025/1072A61F 2/186A61M 2029/025A61M 25/005A61M 25/0102A61M 25/1006A61M 25/1011A61B 2017/22051A61M 25/0138A61F 2/82A61B 17/3421A61M 25/10A61M 2025/109A61M 25/0026A61F 2/90A61M 2210/1028A61M 2025/1079A61B 5/6852A61M 25/09A61M 2025/0177A61M 25/0082A61B 17/3403A61F 11/20
59
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Sinusitis and other disorders of the ear, nose and throat are diagnosed and/or treated using minimally invasive approaches with flexible or rigid instruments. Various methods and devices are used for remodeling or changing the shape, size or configuration of a sinus ostium or duct or other anatomical structure in the ear, nose or throat; implanting a device, cells or tissues; removing matter from the ear, nose or throat; delivering diagnostic or therapeutic substances or performing other diagnostic or therapeutic procedures. Introducing devices (e.g., guide catheters, tubes, guidewires, elongate probes, other elongate members) may be used to facilitate insertion of working devices (e.g. catheters e.g. balloon catheters, guidewires, tissue cutting or remodeling devices, devices for implanting elements like stents, electrosurgical devices, energy emitting devices, devices for delivering diagnostic or therapeutic agents, substance delivery implants, scopes etc.) into the paranasal sinuses or other structures in the ear, nose or throat.

Claims

exact text as granted — not AI-modified
1 .- 10 . (canceled) 
     
     
         11 . A method, comprising:
 (a) inserting a catheter into a nasal cavity of a patient, the catheter including a balloon and a stent positioned over the balloon;   (b) positioning the balloon and the stent in a targeted anatomical passageway in the nasal cavity   (c) expanding the balloon within the targeted anatomical passageway while the stent is positioned over the balloon, the stent engaging adjacent tissue in the targeted anatomical passageway; and   (d) removing the catheter from the nasal cavity, the stent remaining engaged with the adjacent tissue in the targeted anatomical passageway after the catheter is removed from the nasal cavity.   
     
     
         12 . The method of  claim 11 , the balloon being in a non-expanded state during the act of inserting the catheter into the nasal cavity. 
     
     
         13 . The method of  claim 11 , the targeted anatomical passageway comprising an ostium of a sinus. 
     
     
         14 . The method of  claim 11 , the act of expanding the balloon resulting in dilation of the targeted anatomical passageway. 
     
     
         15 . The method of  claim 11 , the stent including a therapeutic substance, such that the stent elutes the therapeutic substance while being engaged with the adjacent tissue in the nasal cavity after the catheter is removed from the nasal cavity. 
     
     
         16 . The method of  claim 11 , the stent defining a cylindrical shape. 
     
     
         17 . The method of  claim 11 , the stent being formed of a resilient material. 
     
     
         18 . The method of  claim 11 , further comprising inserting an introducing device in the nasal cavity, the act of inserting the catheter into the nasal cavity comprising advancing the catheter along the introducing device. 
     
     
         19 . The method of  claim 18 , the introducing device comprising a guidewire. 
     
     
         20 . The method of  claim 11 , the stent comprising a metallic material. 
     
     
         21 . The method of  claim 11 , the stent comprising a polymeric material. 
     
     
         22 . The method of  claim 11 , the stent comprising a foam material. 
     
     
         23 . The method of  claim 11 , the stent comprising a plastically deformable material. 
     
     
         24 . The method of  claim 11 , the stent comprising a super elastic material. 
     
     
         25 . The method of  claim 11 , the stent comprising a chain-link structure. 
     
     
         26 . The method of  claim 11 , the stent comprising polyurethane. 
     
     
         27 . The method of  claim 11 , the stent comprising polyethylene. 
     
     
         28 . The method of  claim 11 , the stent comprising a radiopaque coating. 
     
     
         29 . A method, comprising:
 (a) inserting a catheter into a nasal cavity of a patient, the catheter including a balloon and a stent positioned over the balloon, the balloon and the stent each being in a non-expanded state during the act of inserting the catheter into the nasal cavity of the patient;   (b) positioning the balloon and the stent in a targeted anatomical passageway in the nasal cavity;   (c) expanding the balloon within the nasal cavity while the stent is positioned over the balloon in the targeted anatomical passageway, thereby expanding the stent, the expanded stent engaging adjacent tissue in the targeted anatomical passageway;   (d) transitioning the balloon to a non-expanded state, the expanded stent remaining engaged with the adjacent tissue in the targeted anatomical passageway during the act of transitioning the balloon to the non-expanded state; and   (e) removing the catheter from the nasal cavity with the balloon in the non-expanded state, the expanded stent remaining engaged with the adjacent tissue in the targeted anatomical passageway after the catheter is removed from the nasal cavity.   
     
     
         30 . An apparatus, comprising:
 (a) a catheter, the catheter comprising:
 (i) a balloon, and 
 (ii) a shaft extending proximally from the balloon, the shaft having a length sufficient to enable positioning of the balloon in a targeted anatomical passageway in a nasal cavity of the patient while a proximal end of the shaft remains external to the patient; and 
   (b) a metallic stent, the metallic stent being configured to fit over the balloon of the catheter,   the balloon being operable to inflate to thereby transition the metallic stent from a contracted state to an expanded state,   the metallic stent in the expanded state being operable to bear against a sidewall of the targeted anatomical passageway in the nasal cavity.

Join the waitlist — get patent alerts

Track US2019314620A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.